insulin aspart


Novo Nordisk


Firma Chun Cheong
Concise Prescribing Info
Insulin aspart
Dosage/Direction for Use
Individualized dosing. Used in combination w/ intermediate-acting or long-acting insulin given at least once daily. Usual insulin requirement: 0.5-1 u/kg/day. Must be used w/ Novofine or Novotwist disposable needles up to a length of 8 mm.
Should be taken with food: Administer immediately before or after meals.
Special Precautions
Inadequate dosing or discontinuation of treatment especially in type 1 diabetes may lead to hyperglycaemia & diabetic ketoacidosis; omission of a meal or unplanned, strenuous physical exercise may lead to hypoglycaemia; concomitant illness, especially infections & feverish conditions; transferring from other insulins; risk of CHF when used in combination w/ thiazolidinediones; insulin antibodies. May impair ability to drive or operate machinery. Pregnancy & lactation.
Adverse Reactions
Hypoglycaemia. Urticaria, rash, eruptions; refraction disorders; diabetic retinopathy; lipodystrophy; inj site reactions, oedema.
Drug Interactions
Reduced patient's insulin requirements w/ oral antidiabetics, MAOIs, β-blockers, ACE inhibitors, salicylates, anabolic steroids & sulphonamides. Increased patient's insulin requirements w/ OCs, thiazides, glucocorticoids, thyroid hormones, sympathomimetics, growth hormone & danazol. Increased or decreased insulin requirements w/ octreotide/lanreotide. Intensified/reduced hypoglycaemic effects of insulin w/ alcohol.
ATC Classification
A10AD05 - insulin aspart ; Belongs to the class of intermediate-acting combined with fast-acting insulins and analogues. Used in the treatment of diabetes.
A10AB05 - insulin aspart ; Belongs to the class of fast-acting insulins and analogues. Used in the treatment of diabetes.
NovoRapid penfill 100 U/mL
3 mL x 5 × 1's
NovoRapid FlexPen 100 U/mL
(pre-filled pen) 3 mL x 5 × 1's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in